(MENAFN- GlobeNewsWire - Nasdaq) Opportunities in the COVID-19 diagnostics market include growing demand for rapid and precise diagnostic tests, especially mass and molecular diagnostics, innovation in at-home testing kits, and improvements in healthcare infrastructure. Enhanced governmental support and tech integration further bolster market growth.

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "COVID-19 Diagnostics Market Report by Product Type, Sample Type, Test Type, Mode, End Use, and Region 2025-2033" report has been added to ResearchAndMarkets's offering.
The global COVID-19 diagnostics market size reached USD 58.3 Billion in 2024. Looking forward, the publisher expects the market to reach USD 29.0 Billion by 2033.
COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth.

Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

Key Questions Answered in This Report

• What was the size of the global COVID-19 diagnostics market in 2024?
• What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
• What are the key factors driving the global COVID-19 diagnostics market?
• What is the breakup of the global COVID-19 diagnostics market based on the product type?
• What is the breakup of the global COVID-19 diagnostics market based on the sample type?
• What is the breakup of the global COVID-19 diagnostics market based on the test type?
• What is the breakup of the global COVID-19 diagnostics market based on the mode?
• What is the breakup of the global COVID-19 diagnostics market based on the end use?
• What are the key regions in the global COVID-19 diagnostics market?
• Who are the key players/companies in the global COVID-19 diagnostics market?

Competitive Landscape:

• Abbott Laboratories
• Becton Dickinson and Company
• bioMerieux SA
• Bio-Rad Laboratories
• Danaher Corporation
• F. Hoffman-La Roche Ltd. (Roche Holding AG)
• Luminex Corporation
• PerkinElmer Inc.
• Quest Diagnostics Incorporated
• Robert Bosch GmbH
• Seegene Inc.
• Siemens Aktiengesellschaft
• Thermo Fisher Scientific Inc.

Key Market Segmentation:
Breakup by Product Type:

• Reagents and Kits
• Instruments
• Others

Breakup by Sample Type:

• Nasopharyngeal Swabs
• Oropharyngeal Swabs
• Nasal Swabs
• Blood
• Others

Breakup by Test Type:

• Molecular (RT-PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing
• Others

Breakup by Mode:

• Point-of-Care (PoC)
• Non-Point-of-Care (Non-PoC)

Breakup by End Use:

• Laboratories
• Hospitals
• Diagnostic Centers and Clinics
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN09102025004107003653ID1110174291